Cannabis company Tilray shares jump 11% after announcing deal with Swiss drugmaker NovartisThe marijuana company would work with Novartis' generic drug business Sandoz, and supply non-smokable and non-combustible medical cannabis products where it is legally allowed.[Collection]

The marijuana company would work with Novartis' generic drug business Sandoz, and supply non-smokable and non-combustible medical cannabis products where it is legally allowed.https://www.cnbc.com/2018/12/18/tilray-shares-jump-after-announcing-deal-with-swiss-drugmaker-novartis.html

No comments:

Post a Comment